about
Mechanisms of Candida biofilm drug resistanceAneuploidy and drug resistance in pathogenic fungiComparative lipidomics in clinical isolates of Candida albicans reveal crosstalk between mitochondria, cell wall integrity and azole resistanceComparative lipidomics of azole sensitive and resistant clinical isolates of Candida albicans reveals unexpected diversity in molecular lipid imprints.Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazoleUPC2 is universally essential for azole antifungal resistance in Candida albicans.Pivotal role for a tail subunit of the RNA polymerase II mediator complex CgMed2 in azole tolerance and adherence in Candida glabrataDisruption of the transcriptional regulator Cas5 results in enhanced killing of Candida albicans by FluconazoleMethylene Blue-Mediated Photodynamic Inactivation Followed by Low-Laser Therapy versus Miconazole Gel in the Treatment of Denture Stomatitis.Lipidomics and in vitro azole resistance in Candida albicans.The global regulator Ncb2 escapes from the core promoter and impacts transcription in response to drug stress in Candida albicans.Microbial and fungal protease inhibitors--current and potential applications.The effect of biomaterials and antifungals on biofilm formation by Candida species: a review.Fatal Cases of Bloodstream Infection by Fusarium solani and Review of Published Literature.Ncb2 is involved in activated transcription of CDR1 in azole-resistant clinical isolates of Candida albicans.Fungal Biofilms: Update on Resistance.Adhesion-dependent rupturing of Saccharomyces cerevisiae on biological antimicrobial nanostructured surfaces.Kinetic analysis, expression pattern, and production of a recombinant fungal protease inhibitor of tasar silkworm Antheraea mylitta.An Update on Candida tropicalis Based on Basic and Clinical ApproachesCgMED3 Changes Membrane Sterol Composition To Help Candida glabrata Tolerate Low-pH Stress.In vitro effects of promethazine on cell morphology and structure and mitochondrial activity of azole-resistant Candida tropicalis.
P2860
Q26827521-A87986B3-7F09-4C7E-8E09-53CA5D5AC2D7Q27011632-4E51C8EF-B766-4B0A-9222-24A14EA0BE93Q28480747-37EA276B-A5C4-4534-B76E-5F4FCCFB9DF4Q33894971-981AD655-58B8-476C-871D-91B6D73F66D6Q33939052-0D4FA09E-FA6B-49D7-B161-4346C1CA063EQ34057076-157F2010-F777-4DB9-A391-7F71906CFCABQ34298870-EC7E1AC1-DCFD-4B16-9044-637C801BECF0Q34596791-85EE71B2-0EC4-496F-97CA-DECCF6210399Q35777153-ED1B7549-6EF3-4D2F-A7AC-822F7195D040Q36596097-C60D41AA-2E49-4A4F-9957-BC55E6F87EAEQ37739596-668418D3-5661-440C-AFAF-C802D86E0CAEQ37973268-D831FDF5-EAA1-4B07-9D31-2441023336FFQ38009721-20E0E4C6-0F32-4275-B45F-EEE4E31F3519Q38626372-6AF3A81C-FF91-4150-9626-25AE77DCDC49Q38627814-1517A6CE-7A6C-4355-B34B-3FC2DCB5754EQ38817837-CF42672E-CF69-4799-A3FE-A52FC6A16849Q41762907-F0F0F3FC-2A28-40BC-BF0D-F25750339D6EQ42011828-94FA428B-A000-4100-9832-4A228ADF784EQ42682766-F219D1D9-432C-42AE-9547-FDE2E3BBDF07Q47969153-13B0A661-5B6B-4673-B9FD-4B7630106E8BQ50053442-93A5FE72-F238-4C13-8B37-AC1A87EFFAC4
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Genetic Basis of Antifungal Drug Resistance
@ast
Genetic Basis of Antifungal Drug Resistance
@en
type
label
Genetic Basis of Antifungal Drug Resistance
@ast
Genetic Basis of Antifungal Drug Resistance
@en
prefLabel
Genetic Basis of Antifungal Drug Resistance
@ast
Genetic Basis of Antifungal Drug Resistance
@en
P2860
P1476
Genetic Basis of Antifungal Drug Resistance
@en
P2093
Chelsea Marie
P2860
P2888
P304
P356
10.1007/S12281-009-0021-Y
P577
2009-09-01T00:00:00Z
P5875
P6179
1030485717